TP53 and Myocardial fibrosis: However, these studies did not determine whether short term functional improvement seen in response to p53 abrogation is due to a decreased rate of myocardial fibrosis, a well established risk factor for arrhythmia, cardiomyopathy and CHF [24], [25].